by These devices analyze resonance impedance data to diagnose conditions like velopharyngeal insufficiency, allergies, cleft palates, and sinonasal tumors with high accuracy. Nasometry has made objective evaluation possible by quantifying nasalance scores, assisting in therapy planning and monitoring treatment efficacy. Nasometry equipment offers reliable, reproducible, and non-invasive measurements which help clinicians to accurately diagnose and manage nasal pathologies.
The Global Nasometry Devices Market is estimated to be valued at US$ 250.9 Mn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period 2024 to 2031.
Key Takeaways
Key players: Key players operating in the nasometry devices market are GM Instruments Ltd., Rose Medical Solutions Ltd., PENTAX Medical, Otopront GmbH, BioRESEARCH Associates, Inc., Medtronic, Homoth Medizinelektronik, Recorders Medicare Systems Private Limited, Atmos MedizinTechnik GmbH Co.KG, Collin Medical, Euroclinic MediCare Solutions, SWORD MEDICAL LTD., Glottal Enterprises Incorporated, and Vivos Therapeutics Inc.
Growing demand: Rising prevalence of nasal disorders like nasal pathologies, cleft palates, allergies, and rising demand for accurate diagnostic tools are major factors fueling the Nasometry Devices Market Growth. The demand is significantly high from hospitals, ENT clinics, speech therapy centers to help diagnose and manage these conditions.
Global expansion: Key players are expanding their geographical footprint through new product launches, partnerships and distribution agreements to cater to the growing needs in developing nations. Owing to rising medical tourism and availability of low-cost treatment options, markets in Asia Pacific and Latin America are estimated to witness highest growth during the forecast period.
Market Key Trends
Technological advancements are a key trend shaping the nasometry devices market. Players are focusing on developing advanced nasometry systems integrated with statistical modeling software and hardware upgrades to provide efficient cross-sectional analysis, improve workflow, analysis speed and generate automated reports. Miniaturization of device sizes along with portable variants also allow for point-of-care testing and telehealth applications. These factors are expected to boost the adoption of technologically advanced nasometry devices in the coming years.
Porter’s Analysis
Threat of new entrants: The nasometry devices market requires high investment for R&D as well as compliance with regulatory standards which poses high entry barriers for new players.
Bargaining power of buyers: Individual consumers have low bargaining power however hospitals and clinics can negotiate on pricing and discounts due to bulk purchasing power.
Bargaining power of suppliers: The suppliers of specialized components and technologies have some bargaining power being limited in number however overall bargaining power of suppliers is moderate.
Threat of new substitutes: There are limited substitute available for nasometry devices hence threat is low.
Competitive rivalry: The market has few global players however regional and local presence of manufacturers increases competitive rivalry.
Geographical Regions
North America region holds majority share of the nasometry devices market in terms of value owing to advanced healthcare facilities and increasing prevalence of ENT disorders.
Asia Pacific region is witnessing fastest growth rate attributed to growing awareness, rise in healthcare expenditure and expansion of key players to tap potential in developing countries of the region.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
